Fresenius Medical Care Valuation

Q: What is the Fair Price of FMS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

FMS ($21.39) is trading below our estimate of [[fair value]] ($69.69)

Is FMS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FMS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: FMS ($21.39) is trading below our estimate of fair value ($69.69)

Significantly Below Fair Value: FMS is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for FMS?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for FMS. This is calculated by dividing FMS's market cap by their current preferred multiple.
What is FMS's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	n/a

FMS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.2x
Enterprise Value/EBITDA	9.5x
PEG Ratio	0.9x

Price to Earnings Ratio vs Peers

How does FMS's PE Ratio compare to its peers?

The above table shows the PE ratio for FMS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	27.8x
DVA DaVita	15.3x	4.3%	US$12.3b
CHE Chemed	27.8x	8.8%	US$8.3b
DGX Quest Diagnostics	21.3x	11.7%	US$17.8b
LH Labcorp Holdings	46.8x	20.5%	US$20.3b
FMS Fresenius Medical Care	17.9x	19.3%	US$11.8b

Price-To-Earnings vs Peers: FMS is good value based on its Price-To-Earnings Ratio (17.9x) compared to the peer average (27.8x).

Price to Earnings Ratio vs Industry

How does FMS's PE Ratio compare vs other companies in the US Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	20.9%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	20.9%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: FMS is good value based on its Price-To-Earnings Ratio (17.9x) compared to the US Healthcare industry average (25.4x).

Price to Earnings Ratio vs Fair Ratio

What is FMS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FMS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	17.9x
Fair PE Ratio	35.4x

Price-To-Earnings vs Fair Ratio: FMS is good value based on its Price-To-Earnings Ratio (17.9x) compared to the estimated Fair Price-To-Earnings Ratio (35.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.